C.R. Bard Raises Dividend

Another great stock has raised its dividend. This time it’s C.R. Bard ($BCR). Here’s a description from Hoovers:

C. R. Bard is no upstart in the world of medical devices. The company has been in the business for more than a century and introduced the Foley urological catheter (still one of its top sellers) in 1934. Its products fall into four general therapeutic categories: vascular, urology, oncology, and surgical specialties. Among other things, the company makes stents, catheters, and guidewires used in angioplasties and other vascular procedures; urology catheters and products used to treat urinary incontinence; and catheters for delivering chemotherapy treatments. Its line of specialty surgical tools, made by subsidiary Davol, includes devices used in laparoscopic and orthopedic procedures and for hernia repair.

Bard is raising the quarterly dividend from 18 cents to 19 cents per share. The annualized yield is still puny — just 0.69%. But if you had bought the shares 25 years ago, you’d currently be yielding over 12.4%.

The shares aren’t chaep. Bard currently goes for 17 times this year’s earnings estimate.

Posted by on June 10th, 2011 at 9:38 am


The information in this blog post represents my own opinions and does not contain a recommendation for any particular security or investment. I or my affiliates may hold positions or other interests in securities mentioned in the Blog, please see my Disclaimer page for my full disclaimer.